Source: BioSpace

GreenLight: GreenLight Biosciences Raises $17 Million to Scale Up COVID-19 Vaccine Manufa...

GreenLight Biosciences closed an oversubscribed $17 million "special purpose funding round" in order to expand its scalable mRNA manufacturing capability for its mRNA COVID-19 vaccine. The goal is to be able to produce billions of doses.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Andrey J. Zarur's photo - President & CEO of GreenLight

President & CEO

Andrey J. Zarur

CEO Approval Rating

86/100

GreenLight is a bio-performance company that develops RNA-based healthcare products for agriculture and pharmaceutical applications. Read more